Narmada Gelatines Limited is a leading manufacturer of gelatine and collagen peptides, primarily serving the food, pharmaceutical, and photographic industries. The company operates in India and has a strong competitive position due to its low debt levels and high operational efficiency, reflected in its robust margins and return metrics.
Narmada Gelatines generates revenue through the production and sale of gelatine and collagen-based products, leveraging its strong relationships with major food and pharmaceutical companies. The company benefits from pricing power due to its high-quality products and established market presence.
Fluctuations in raw material prices, particularly pork and bovine hides
Changes in demand from the food and pharmaceutical sectors
Regulatory changes affecting food safety and pharmaceutical standards
Expansion into new international markets
Technological disruption in gelatine alternatives (e.g., plant-based substitutes)
Regulatory changes impacting production processes
Increased competition from international gelatine manufacturers
Potential for price wars in the specialty chemicals market
Low liquidity risk due to a current ratio of 3.59
Potential risks associated with currency fluctuations if expanding internationally
moderate - the company's performance is linked to consumer spending in the food and pharmaceutical sectors, which are sensitive to economic cycles.
Interest rates have minimal direct impact on Narmada Gelatines, given its low debt levels. However, higher rates could affect consumer spending indirectly.
minimal - the company has a low debt-to-equity ratio of 0.05, reducing its reliance on credit.
growth - due to strong revenue and net income growth rates, appealing to investors seeking capital appreciation.
moderate - the stock has shown significant returns over the past year, indicating some volatility.